Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D06WUK
|
|||
| Former ID |
DIB014526
|
|||
| Drug Name |
Carlumab
|
|||
| Synonyms |
CCL-2; CNTO-888; Anti-MCP1 monoclonal antibodies, Centocor; CCL2 monoclonal antibody (infusion, cancer), Centocor
Click to Show/Hide
|
|||
| Drug Type |
Antibody
|
|||
| Indication | Pulmonary fibrosis [ICD-11: CB03.4; ICD-10: J84.1] | Phase 2 | [1], [2] | |
| Company |
Janssen biotech
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 771). | |||
| REF 2 | Carlumab, an anti-C-C chemokine ligand 2 monoclonal antibody, in combination with four chemotherapy regimens for the treatment of patients with solid tumors: an open-label, multicenter phase 1b study. Target Oncol. 2015 Mar;10(1):111-23. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.